Lake Street Capital Boosts Envoy Medical (NASDAQ:COCH) Price Target to $6.00

Envoy Medical (NASDAQ:COCHGet Free Report) had its target price boosted by research analysts at Lake Street Capital from $3.00 to $6.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Lake Street Capital’s price target would indicate a potential upside of 23.97% from the stock’s current price.

Separately, Northland Securities initiated coverage on shares of Envoy Medical in a research note on Thursday, December 21st. They set an “outperform” rating on the stock.

View Our Latest Stock Analysis on Envoy Medical

Envoy Medical Trading Up 8.0 %

Shares of COCH traded up $0.36 during trading hours on Wednesday, reaching $4.84. 51,000 shares of the company traded hands, compared to its average volume of 414,020. The firm has a fifty day moving average price of $3.40. Envoy Medical has a 12 month low of $0.75 and a 12 month high of $11.72.

Institutional Investors Weigh In On Envoy Medical

A hedge fund recently bought a new stake in Envoy Medical stock. Weiss Asset Management LP acquired a new position in shares of Envoy Medical, Inc. (NASDAQ:COCHFree Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 20,000 shares of the company’s stock, valued at approximately $37,000. Weiss Asset Management LP owned approximately 0.10% of Envoy Medical at the end of the most recent reporting period. Institutional investors own 8.59% of the company’s stock.

Envoy Medical Company Profile

(Get Free Report)

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices, such as auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.

See Also

Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with's FREE daily email newsletter.